Moviprep

Polyethylene glycol electrolyte solution with ascorbic acid, the active ingredient in Moviprep, is a laxative presented as an oral solution for oral use. It is employed to cleanse the bowel before colonoscopy or sigmoidoscopy in adult patients, facilitating clear visualization of the colon during endoscopic procedures.

GNH USA supplies Moviprep as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export. Documentation includes batch release certificates and certificates of analysis.

Moviprep is an osmotic laxative used for bowel preparation prior to endoscopic examinations of the colon.

Colonoscopy: provides thorough bowel cleansing to enable clear visualization of the entire colon during the procedure. Sigmoidoscopy: cleanses the distal colon, facilitating safe and effective examination of the sigmoid and rectum. Radiologic colon imaging: ensures adequate bowel preparation for contrast studies such as CT colonography.

Moviprep may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea - Abdominal bloating - Abdominal pain - Vomiting - Thirst - Mild electrolyte disturbance

Serious or Rare Side Effects: - Severe dehydration - Severe electrolyte imbalance (e.g., hypokalemia, hyponatremia) - Renal impairment - Allergic reaction (rash, anaphylaxis) - Colonic perforation (rare)

Before prescribing Moviprep, clinicians should consider several precautionary measures to ensure patient safety.

Renal function: assess renal function in patients with known kidney disease. Electrolyte status: check serum electrolytes prior to administration. Cardiovascular disease: use cautiously in patients with heart failure or uncontrolled hypertension. Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. Pediatric use: not recommended for children without specific guidance. Store at ambient temperature: keep in original container, protect from moisture and light.

Moviprep can interact with other medicines, affecting electrolyte balance or drug clearance.

Major Interactions (Avoid): - Lithium: increased risk of lithium toxicity due to altered renal clearance. - Antidiabetic agents: may enhance hypoglycaemic effect. - Loop diuretics: can exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor potassium levels during therapy. - NSAIDs: may affect renal function and fluid balance.